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Background: The relationship between sleep and mood regulation is well known, and some 
reports suggest a key role of sleep-related breathing disorders (SRBD) in the development of 
the symptomatology of depression, even if no conclusive data are actually found in the clinical 
literature. The aim of this study was to assess the relationship between SRBD and depressive 
symptoms in a population of school-aged children.
Methods: The study population comprised 94 children affected by SRBD and 107 healthy 
children. To identify the severity of SRBD, an overnight respiratory evaluation was performed. 
All subjects filled out the Italian version of the Children Depression Inventory (CDI) to screen 
for the presence of depressive symptoms.
Results: The group with SRBD showed higher CDI scores than the group without SRBD, 
with a positive correlation found between CDI scores, apnea-hypopnea index, and oxygen 
desaturation index values. Logistic regression showed that an apnea-hypopnea index $ 3 and an 
oxygen desaturation index $ 1 could be risk factors for development of depressive symptoms. 
According to receiver-operating characteristic curve analysis, the cutoff point for the apnea-
hypopnea index that could cause a pathological CDI score ($19) was .5.66, and the cutoff 
point for the oxygen desaturation index was .4.2. The limitations of this study are that our data 
are derived from one single psychometric test and not from a complete psychiatric evaluation, 
and our subjects came from a small group in southern Italy.
Conclusion: Our results suggest the importance of mood assessment in children affected 
by SRBD.
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Introduction
Depression in childhood is a disabling condition associated with increased psychosocial 
and physical morbidity and mortality.1,2 Early-onset depression in particular seems to 
be characterized by pervasive dysfunction throughout life.3,4 In fact, depression during 
childhood and adolescence represents a significant public health concern, affecting 
about 1%–2% of prepubertal children and about 3%–8% of adolescents,5–7 accompanied 
by a poor psychosocial outcome, multiple comorbid conditions, and a high risk of 
suicide and substance abuse, suggesting the necessity of early diagnosis and treatment. 
Moreover, early onset depression increases the risk of subsequent depressive episodes 
later in adolescence and adulthood, ranging from 45% to 72% over 3–7 years.8,9 Because 
of the high costs associated with pediatric depression, the past 10 years has seen a 
growing interest in its prevention.10 A link between mood dysfunction and sleep is 
also known and well established,11,12 and includes difficulties such as falling asleep,13,14 
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fragmented sleep,15 symptoms of hypersomnia,16 and sleep-
related breathing disorders (SRBD).17
SRBD are disorders of breathing during sleep characterized 
by prolonged partial upper airway obstruction, intermittent 
complete or partial obstruction (obstructive apnea or 
hypopnea), or both prolonged and intermittent obstruction 
that disrupts normal ventilation during sleep, normal sleep 
patterns, or both.18 In general, SRBD seems to play a key 
role in the symptomatology of depression, especially in 
adulthood,19–21 even if the causal mechanism remains unclear. 
In fact, it is unknown if depression in patients with obstructive 
sleep apnea syndrome could be considered the primary 
consequence or if it occurs secondary to symptoms related 
to obstructive sleep apnea syndrome (eg, sleepiness, sleep 
problems, irritability, social withdrawal), or to other factors 
related to the syndrome (eg, obesity, hypertension).22–25 
Moreover, depressive symptoms are so frequent in adults 
affected by the syndrome that the current recommendation 
in these circumstances is that the mood disorder should be 
considered as secondary to the medical disorder and not as 
a distinct psychiatric entity.22,25
In 2004, O’Brien et al suggested that the link between 
different grades of SRBD and behavior could be exemplified 
by the effects of primary nocturnal snoring as a trigger 
of neurobehavioral def icits, such as attention-deficit 
hyperactivity disorder symptoms, social problems, and 
symptoms of anxiety and/or depression in children.26 On the 
other hand, a clinical study shows that children with SRBD 
tend to have more internalizing symptoms,27 such as anxiety 
and depressive traits, but without a specific explanation for 
the putative causal role of SRBD. The aim of this study was 
to assess the prevalence of symptoms of depression in a 
school-aged population of children affected by SRBD.
Materials and methods
Participants
The study population comprised 94 children with SRBD 
(49 males and 45 females, mean age 10.15 ± 2.60 years) 
consecutively recruited between January 2011 and May 2012 
from the Sleep Clinic for Developmental Age at the Second 
University of Naples. Exclusion criteria were psychiatric 
illness (ie, schizophrenia, psychosis, attention-deficit hyper-
activity disorder), mental retardation (IQ , 75), neurological 
disorder (epilepsy, neuromuscular disorders, cerebral palsy), 
overweight (body mass index $ 85th centile) or obesity 
(body mass index $ 95th centile), and referral for sleep 
complaints other than SRBD. Exclusion of obese subjects 
was due to evidence of a correlation between body mass 
index and depression in children.28 The control group con-
sisted of 107 healthy children (43 males and 64 females, 
mean age 10.2 ± 2.44 years) enrolled in schools within 
the Campania region. All subjects were recruited from the 
same urban area, and were of Caucasian origin and middle 
socioeconomic status. Informed consent was obtained from 
all parents. The investigation was carried out in accordance 
with the principles of the Declaration of Helsinki as revised 
in 2000. The departmental ethics committee of the Second 
University of Naples approved the study (protocol number 
003/2011).
Sleep evaluation
In all children (with or without SRBD) a cardiorespiratory 
device (Embletta X10; Embletta PDS, MedCare Flaga, 
Iceland) was used to perform an overnight respiratory 
evaluation. The Embletta device is used specifically to detect 
the presence of SRBD and to assess its severity, is suitable 
for use both in a sleep laboratory and at home,29 and has been 
validated against full polysomnography.30 All evaluations 
were performed overnight in the sleep laboratory at the Sleep 
Center for Developmental Age of Child and Adolescent 
Neuropsychiatry, Department of Second University of 
Naples. All recordings started at the subjects’ usual bedtime 
and continued until spontaneous morning awakening.
The parameters measured were: nasal airflow, using 
two appropriately placed thermistors; thoracoabdominal 
movements via two piezoelectric bands; pulse oximetry 
using a finger probe; snoring episodes detected via a vibration 
sensor placed anterior to the sternocleidomastoid muscle; and 
continuous actigraphy to monitor and record body position. 
Recordings were analyzed manually using the device-
specific software (Somnologica for Embletta 3.3; Embla, 
Broomfield, CO). Sleep onset was estimated as the beginning 
of the first 10-minute period not containing any changes in 
body position and morning awakening as the end of the last 
such 10-minute period.31 Estimated sleep time was calculated 
as the time between sleep onset and morning awakening. 
Recordings were analyzed for artefactual or uninterpretable 
periods of nasal flow, thoracic effort, abdominal effort, or 
oximetry. Movement periods and artefactual or uninterpretable 
periods were excluded from the estimated sleep time if they 
lasted for more than 5 minutes, and the corrected estimated 
sleep time was calculated.31 A minimum of 5 hours of corrected 
estimated sleep time was required.
All the recordings were visually scored by one of the 
investigators (MC) according to pediatric criteria.32–35 
Specifically, obstructive apnea was defined as cessation 
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of airflow, lasting for at least two breaths, in the presence 
of paradoxical ribcage and abdominal movements. The 
 hypopnea index was defined as a reduction in the nasal 
flow curve signal by more than 50% that was accompanied 
by either oxygen desaturation or arousal. Central apnea 
was defined as the absence of airflow at both the nose and 
mouth with absent inspiratory effort throughout the duration 
of the event, lasting 20 seconds or longer, or two missed 
breaths accompanied by at least a 3% oxygen desaturation, 
an arousal, or an awakening. The apnea-hypopnea index 
(AHI) was defined as the number of obstructive apneas and 
hypopneas per hour of sleep,32,33,36 and the lowest oxygen 
saturation value and number of desaturation events by 4% 
and to 90% were counted. The oxygen desaturation index 
(ODI), defined as events per hour, was also calculated. An 
AHI and ODI # 1 per hour were considered to be normal 
according to American Thoracic Society criteria.32,33
Screening for depressive symptoms
All children filled out the Italian version of the Children 
Depression Inventory (CDI)37 to screen for the presence of 
depressive symptoms. The CDI is a self-rating scale widely 
used to assess depressive symptomatology in children and 
adolescents aged 8–17 years (Cronbach’s α = 0.80). It is 
comprised of 27 Likert-like items, with scores ranging from 
0 to 2, and yields total scores from 0 to 54, with higher scores 
reflecting greater symptomatology. According to Italian 
validation criteria, a score of 19 is considered suggestive of 
depressive symptoms.38 In our study, the five CDI subscales 
(negative mood, interpersonal problems, ineffectiveness, 
anhedonia, negative self-esteem)39,40 were not considered 
because of lack of normative data for the Italian version of 
the test.38
Statistical analysis
A t-test was performed in order to determine if there were any 
differences in age, AHI, ODI, and CDI values between the 
two groups. The Chi-square test was used to describe the sex 
distribution. The Pearson’s correlation test was computed to 
analyze the relationship among CDI scores with respiratory 
indices (AHI and ODI). A logistic regression was generated to 
estimate the odds ratio, respectively, of AHI $ 3 and ODI $ 1 
being associated with depressive symptoms. P values , 0.05 
were considered to be statistically significant. Bonferroni 
correction was applied. All data were coded and analyzed 
using the commercially available Statistica 6.0 package 
for Windows (StatSoft Inc, Tulsa, OK). Receiver-operating 
characteristic curve analysis was calculated using MedCalc 
software version 7.3.0.1 (MedCalc Software, Mariakerke, 
Belgium) in order to evaluate the cutoff points for AHI and 
ODI that could cause depressive symptoms.
Results
The two groups did not differ in sex (Chi-square 2.414; 
P = 0.12), age (P = 0.52), or body mass index (P = 0.649) 
distribution, as shown in Table 1. The group with SRBD 
had higher mean CDI scores and a rate of pathological CDI 
scores ($19) than the control group, as reported in Table 1. 
The Pearson’s correlation test, computed for the whole study 
population, showed a positive correlation between CDI 
score and AHI (r = 0.4246; P , 0.001) and ODI (r = 0.4393; 
P , 0.001) values. Logistic regression showed that both 
AHI $ 3 (odds ratio 3.0565; 95% confidence interval [CI]: 
1.6758–5.5746) and ODI $ 1 (odds ratio 3.0727; 95% CI: 
1.6727–5.6445) could be considered risk factors for the 
development of depressive symptoms.
Receiver-operating characteristic curve analysis showed 
that the cutoff point for AHI values that could cause a patho-
logical CDI score (ie, $19) was .5.66 (95% CI: 0.680–0.805), 
with a sensitivity of 61.4 (95% CI: 49–72.8) and a specificity 
of 88.5 (95% CI: 81.7–93.4). Moreover, a pathological CDI 
score could be caused by an ODI cutoff point . 4.2 (95% 
CI: 0.58–0.720), with a sensitivity of 38.6 (95% CI: 27.2–51) 
and a specificity of 91.5 (95% CI: 85.4–95.7).
Discussion
In 1976, Guilleminault et al first identified the pediatric 
form of obstructive sleep apnea, and since then SRBD 
has become increasingly recognized as a specific entity 
in childhood.41,42 Further, depression seems to be the most 
common mood disorder associated with obstructive sleep 
apnea syndrome,22–25 although not all studies have found a 
Table 1 Demographic and clinical characteristics of the study 
population
SRBD  
(n = 94)
Control  
(n = 107)
P value*
Age 10.15 ± 2.60 10.20 ± 2.44 NS
Sex M/F 49/45 43/64 NS
BMI 18.93 ± 1.47 19.02 ± 1.33 NS
AhI 8.26 ± 5.77 0.95 ± 0.24 ,0.001
ODI 3.82 ± 3.65 0.30 ± 0.28 ,0.001
CDI (mean values) 21.94 ± 8.07 17.59 ± 3.87 ,0.001
CDI ($19) 50/44 24/83 ,0.001
Note: *P, Bonferroni-corrected value.
Abbreviations: BMI, body mass index; AhI, apnea-hypopnea index; ODI, oxygen 
desaturation index; CDI, Child Depression Inventory; NS, not statistically significant; 
SRBD, sleep-related breathing disorder.
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clear correlation.22–24,43 However, studies of the relationship 
between depressive symptoms and obstructive sleep apnea 
syndrome in adult subjects have had conflicting findings,17,44,45 
although depression seems to be not uncommon in patients 
with obstructive sleep apnea.46 A putative link between 
depression and obstructive sleep apnea syndrome could be 
explained by magnetic resonance maps showing damage in 
the bilateral hippocampus and caudate nuclei, anterior corpus 
callosum, right anterior thalamus, and medial pons.47
Individuals with severe generic sleep problems are more 
likely to have emotional, school attendance, hyperactivity, 
and behavioral difficulties48 than those with no or mild 
sleep complaints. Moreover, patients with SRBD showed 
a high rate of internalizing problems (such as anxiety and 
depression),49 as confirmed by our results that showed a 
higher rate of depressive symptoms in children with SRBD 
than children without SRBD.
On the other hand, sleep problems are a consistent and 
preventable etiological cause of depressive symptoms, 
and the correlation between clinical depressive symptoms 
and AHI (r = 0.4246; P , 0.001) and ODI (r = 0.4393; 
P , 0.001) in our study may be interpreted according to 
this point of view.
In fact, respiratory problems during sleep should not be 
considered a minor problem in childhood, given a report of 
a specific neurocognitive phenotype of pediatric obstructive 
sleep apnea that may reflect a dysfunction in the prefrontal 
cortex.50 In 2010, Torelli et al51 showed a specific alteration 
in hippocampal volume in adults affected by obstructive 
sleep apnea syndrome, indicating abnormality in the limbic 
areas52 which are involved also in the pathophysiology of 
depression,53 as confirmed in a recent report by Canessa 
et al using a combination of neuropsychologic testing and 
voxel-based morphometry.54 Our results also suggest that 
an AHI $ 3 and an ODI $ 1 can be considered consistent 
risk factors for development of depressive symptoms (odds 
ratios 3.0565 and 3.0727, respectively). Therefore, the 
modality used to identify sleep-disordered breathing in 
children affected by mood disorders is clearly important. 
Alternatively, we should take into account some limitations 
of this study, ie, our data are derived from a one single 
psychometric test and not from a complete psychiatric 
evaluation, and our subjects came from a small group from 
Southern Italy. Our findings suggest a key role of mood 
assessment in children affected by SRBD, given that the 
latter may exacerbate the tendency to develop depressive 
symptoms, and also because treatment of SRBD could 
improve or possibly prevent depressive symptoms.55
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